Provided by Tiger Trade Technology Pte. Ltd.

AIM VACCINE

1.805
-0.085-4.50%
Volume:89.00K
Turnover:162.95K
Market Cap:2.21B
PE:-2.80
High:1.880
Open:1.825
Low:1.795
Close:1.890
52wk High:4.450
52wk Low:1.200
Shares:1.23B
HK Float Shares:507.67M
Volume Ratio:0.86
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.644
ROE:-23.23%
ROA:-1.77%
PB:0.72
PE(LYR):-2.80
PS:1.89

Loading ...

AIM Vaccine Submits Additional NMPA Data for Serum-free Rabies Vaccine After Phase III Trial Unblinding

Reuters
·
Aug 03

Puhua Capital-backed Ruivi Technology Lists in Hong Kong, Shares Trade as 07656.hk

Reuters
·
Jul 08

AIM VACCINE Shares Surge Over 8% Intraday Following Board Reshuffle and Accelerated Dual-Listing Strategy

Stock News
·
Jun 24

AIM VACCINE Announces Appointment of Wu Jinian as Executive President

Stock News
·
Jun 10

AIM Vaccine shareholders approve bylaw amendments effective upon NEEQ listing

Reuters
·
Jun 10

AIM Vaccine books RMB525.83 million impairment after suspending mRNA rabies projects and delaying PCV13 launch

Bulletin Express
·
Jun 05

AIM Vaccine Calls 10 June 2026 EGM to Approve Private RMB Share Placement and NEEQ Listing Plan

Bulletin Express
·
May 21

AIM Vaccine announces first extraordinary general meeting

Reuters
·
May 21

AIM Vaccine Announces Resignation of Independent Non-Executive Director

Stock News
·
May 18

AIM Vaccine announces annual general meeting

Reuters
·
May 18

AIM Vaccine independent director Wen Jie resigns amid board reshuffle plan

Reuters
·
May 18

AIM Vaccine Releases 2025 ESG Report: Revenue at RMB 1.17 Billion, RMB 356 Million R&D Spend, Net-Zero Roadmap Outlined

Bulletin Express
·
Apr 27

AIM Vaccine publishes 2025 ESG report

Reuters
·
Apr 27

AIM Vaccine深化研发布局与治理架构调整,2025年营收约人民币11.65673亿元亏损扩大

Bulletin Express
·
Apr 27

AIM VACCINE Shares Surge Over 5% on Plan to List on Beijing Stock Exchange and Imminent Launch of World's First Serum-Free Rabies Vaccine

Stock News
·
Apr 15